MSB 2.52% $1.74 mesoblast limited

As I see it, there are probably three outcomes here:1. Novartis...

  1. 149 Posts.
    lightbulb Created with Sketch. 32

    As I see it, there are probably three outcomes here:

    1. Novartis have cut a deal, of course they have, why wouldn’t they, because THIS IS NOT A DRUG PEOPLE, and SI is a genius – duh!

    2. Novartis have not cut a deal, because they are boneheaded number crunchers, and SI has outflanked them because he’s a genius – duh!

    3. It’s a garden variety CR at $1.50/share, but that’s OK because dilution doesn’t matter, and anyway you don’t lose money until you sell, and it’s probs, no defs strategically brilliant because, actually, did I mention SI is a genius?

watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Mkt cap ! $1.128B
Open High Low Value Volume
$1.78 $1.80 $1.73 $6.076M 3.476M

Buyers (Bids)

No. Vol. Price($)
2 20824 $1.74

Sellers (Offers)

Price($) Vol. No.
$1.74 23759 2
View Market Depth
Last trade - 16.10pm 07/05/2021 (20 minute delay) ?
-0.045 ( 2.86 %)
Open High Low Volume
$1.78 $1.79 $1.73 1037244
Last updated 15.59pm 07/05/2021 (live) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.